Access to Medicines Beyond Standard Approvals

Specialised support for unlicensed medicines and Named Patient Programs under European special access frameworks.

Call Us Now

Unlicensed & Named Patient Medicine Supplier in Europe

Ikris Pharma Network supports healthcare providers with access to unlicensed and unapproved medicines under European special access and Named Patient frameworks.

Named Patient Program (NPP) Support

We assist hospitals and physicians in sourcing medicines for individual patients when approved alternatives are unavailable.

Special Access & Compassionate Use

Our team supports compliant sourcing for:

Rare and life-threatening conditions
Emergency or compassionate use cases
Oncology and critical therapies

Compliance-Focused Approach

All sourcing is conducted in line with applicable local regulations and ethical supply standards.

10000

+patients served

+years of experience

150

+countries served

15000

+medicines range

Ikris Health+ Application: Access 20,000+ Medication at Finger Tip

Your Questions Matter—Let’s Find the Right Solution Together

✔️ Specialized access to unapproved or rare medicines under Named Patient Programs (NPP)
✔️ Reliable sourcing and global supply of Reference Listed Drugs (RLD)
✔️ End-to-end support for Clinical Trial Supplies—timely and compliant delivery
✔️ Licensed pharmaceutical export services with regulatory compliance
✔️ Transparent processes with full documentation and import/export assistance
✔️ Fast, confidential responses from an experienced international team